Thermo Fisher’s West Coast HQ - San Diego Business Journal

FierceBiotechMadrigal continues MASH deal spree with $1B biobucks license for Arrowhead asset rejected by J&J

Endpoints NewsSwiss manufacturing, biotech industry so far unfazed by geopolitics

Endpoints NewsPfizer ends Trillium-related development as R&D spend jumps

Endpoints NewsMicrobiome startup raises $48M for immunotherapy and malnutrition treatments

Endpoints NewsJ&J's IBD combo fails Phase 2 studies, but will move into pivotal testing

FierceBiotechPfizer’s $2.3B Trillium bet ends in failure as remaining CD47 blocker scrapped along with T-cell engager

FierceBiotechSanofi expands AI capabilities, investing $294M to scale Toronto hub

Endpoints NewsMadrigal extends MASH deal streak with Arrowhead drug that J&J didn't want

Endpoints NewsHealthcare organizations are increasingly building their own AI tools

PharmaVoiceWhat’s at stake in Amgen’s showdown with the FDA?

Promega BlogBeyond the Liver: How Liposomal LNPs Are Expanding the Reach of mRNA Delivery

BioPharma DiveVertex earnings get muted investor response